Fixation of breast and prostate cancer tissue
Fixation of breast and prostate cancer tissue
批准号:
6622118
负责人:
CHRISTOPHER B UMBRICHT
金额:
$16.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31
中文摘要
描述(由申请人提供):
基因表达的综合分析正迅速成为可能
不仅适用于选定的模型系统,而且适用于临床组织样品。的
临床组织样品中的基因表达分析已经严重
然而,受限于基于福尔马林的固定的标准实践,
外科病理学 福尔马林影响细胞的质量和数量
可以从固定的组织中提取的大分子。
因此,任何定量分析在历史上都依赖于过剩
组织,这可以获得不损害病理
评价因此,几乎没有材料可从小
样本,从而有效地排除了癌前病变的分析,
早期浸润性癌症,这两者都可能是许多基本问题的关键
关于早期致癌过程。巧合的是,我们正在经历一场
这些小病变的发生率空前增加,
乳腺和前列腺筛查项目越来越成功
癌显然,使这些标本可用于分子方法
提供了一个巨大的机会,以促进我们的知识,
癌发生的阶段。我们建议从两个方面解决这个问题
互补的方法。第一,改进目前不足的方法,
从档案福尔马林固定材料中提取RNA和DNA。核酸
由于不可逆交联大分子中非特异性捕获而造成的损失
将通过优化所有非目标组件的细分来最大限度地减少,
以及利用核酸对高盐中的二氧化硅珠的亲和力
解决方案提取的核酸的模板功能将得到提高
从纯化的多核苷酸中除去不稳定的N-羟甲基加合物。
第二,开发新的固定程序,提高
可扩增的DNA和RNA模板,同时避免了
根据不同的临床和研究,
需求我们刚刚完成了一个试点项目,展示了这种替代方案
基于酒精的固定产生良好的组织病理学,
免疫组化结果,而不损害功能提取
信使RNA,如通过定量实时RT-PCR评估的。固定,无
交联可以满足临床和科学需要。
英文摘要
DESCRIPTION (provided by applicant):
Comprehensive analysis of gene expression is rapidly becoming a possibility
not only for selected model systems, but also for clinical tissue samples. The
analysis of gene expression in clinical tissue samples has been severely
limited, however, by the standard practice of formalin-based fixation in
surgical pathology. Formalin impacts the quality and quantity of cellular
macromolecules that can be extracted from fixed tissue.
Therefore, any quantitative analysis has historically depended on excess
tissue, which could be obtained without compromising the pathologic
evaluation. As a result, there is almost no material available from small
samples, thus effectively precluding analysis of precancerous lesions and
early invasive cancer, both of which may hold the key to many basic questions
about the early carcinogenic process. Paradoxically, we are experiencing an
unprecedented increase in the accrual of these small lesions thanks to
increasing successes in screening programs for both breast and prostate
cancer. Clearly, making these specimens available to molecular methods
presents a tremendous opportunity to advance our knowledge of the initial
phases of carcinogenesis. We propose to address this issue with two
complementary approaches. First, improve the currently insufficient methods of
RNA and DNA extraction from archival formalin fixed material. Nucleic acid
losses due to non-specific trapping in irreversibly crosslinked macromolecules
will be minimized by optimizing the breakdown of all non-target components as
well as using the affinity of nucleic acids for silica beads in high salt
solutions. The template function of extracted nucleic acids will be improved
by removing labile N-methylol adducts from the purified polynucleotides.
Second, develop new fixation procedures improving the extractability of
amplifyable DNA and RNA templates, while avoiding the difficulties of having
to divide limited tissue samples according to various clinical and research
needs. We have just completed a pilot project demonstrating that alternative
alcohol based fixation produces excellent histopathological and
immunohistochemical results without compromising extraction of functional
messenger RNA, as assessed by quantitative real-time RT-PCR. Fixation without
crosslinking may fulfill both clinical and scientific needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and validation of early molecular breast cancer risk markers in benign breast disease
-
批准号:10672947
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2018
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Discovery and validation of early molecular breast cancer risk markers in benign breast disease
-
批准号:10245259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
-
批准号:8234951
-
项目类别:
-
资助金额:$58.33万
-
财政年份:2011
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
-
批准号:8828105
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2011
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
-
批准号:8108116
-
项目类别:
-
资助金额:$56.97万
-
财政年份:2011
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
-
批准号:8461224
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2011
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
-
批准号:8631055
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2011
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
Fixation of breast and prostate cancer tissue
-
批准号:6439088
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2002
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
ROLE OF MAMMALIAN HELICASES IN DNA REPLICATION
-
批准号:3085838
-
项目类别:
-
资助金额:$6.27万
-
财政年份:1989
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
ROLE OF MAMMALIAN HELICASES IN DNA REPLICATION
-
批准号:3085840
-
项目类别:
-
资助金额:$6.91万
-
财政年份:1989
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
ROLE OF MAMMALIAN HELICASES IN DNA REPLICATION
-
批准号:3085841
-
项目类别:
-
资助金额:$7.42万
-
财政年份:1989
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
ROLE OF MAMMALIAN HELICASES IN DNA REPLICATION
-
批准号:3085837
-
项目类别:
-
资助金额:$6.03万
-
财政年份:1989
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
ROLE OF MAMMALIAN HELICASES IN DNA REPLICATION
-
批准号:3085839
-
项目类别:
-
资助金额:$6.52万
-
财政年份:1989
-
负责人:CHRISTOPHER B UMBRICHT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: